City Therapeutics Inc.

City Therapeutics Inc.

CTY - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$175.97M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
City Therapeutics Inc.City Therapeutics Inc.0-18%-0.5

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$175.97 Million
Enterprise Value$5.15 Billion
Earnings per Share$0
Beta0
Outstanding Shares0

Return

Return on Equity17.74%ROE
Return on Assets9.24%
Return on Invested Capital13.12%

Valuation & Multiples

P/E Ratio0P/E Ratio
PEG0PEG
Price to Sales-Price to Sales
Price to Book Ratio-Price to Book Ratio
Enterprise Value to Revenue0.79
Enterprise Value to EBIT2.3
Enterprise Value to Net Income2
Total Debt to Enterprise0.97
Debt to Equity0.49Debt to Equity

Revenue Sources

No data

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About City Therapeutics Inc.

City Therapeutics, Inc. is a biotechnology company specializing in next-generation RNA interference (RNAi) therapeutics. The company is based in Cambridge, MA. The company engineers potent, specific, and durable RNAi trigger molecules co...

Questions & Answers